Dark Forest Capital Management LP Atri Cure, Inc. Transaction History

Dark Forest Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$35.87 - $47.22 $7,676 - $10,105	214 New	214 $8,000
Q2 2022 Aug 15, 2022	BUY	$35.1 - $66.01 $70 - $132	2 New	2 $0
Q1 2022 May 13, 2022	SELL	$57.43 - $71.39 $20,674 - $25,700	-360 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$63.4 - $87.14 $22,824 - $31,370	360 New	360 $25,000
Q3 2021 Nov 12, 2021	SELL	$69.28 - $84.46 $176,040 - $214,612	-2,541 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$64.13 - $80.18 $162,954 - $203,737	2,541 New	2,541 $202,000

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.43B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.